share_log

Baird Maintains Neutral on Medtronic, Lowers Price Target to $93

Benzinga ·  07:35  · Ratings

Baird analyst David Rescott maintains Medtronic (NYSE:MDT) with a Neutral and lowers the price target from $96 to $93.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment